Sanford Health-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sanford Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013634
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center’s medical services include allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox cosmetic, breast cancer risk consultation, breast radiology, cancer risk assessment and cancer screenings. It also provides cardiac electrophysiology, cardiac rehabilitation, cardiology, cardiovascular surgery, centering pregnancy, chemical peels, child life specialists, child services, counselling, family medicine, weight loss surgery, chiropractic, cleft lip and cleft palate, colorectal screenings, colorectal surgery, colposcopy, cosmetic laser treatments, and others. The center also conducts research and clinical trials for advancing disease therapy and prevention. Sanford is headquartered in Sioux Falls, South Dakota, the US.

Sanford Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sanford Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sanford Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sanford Health, Medical Devices Deals, 2011 to YTD 2017 9
Sanford Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sanford Health, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Sanford Health To Acquire Assets Of Clearwater Health 11
Sanford Health Acquires Lake Region Bone & Joint Surgeons 12
Venture Financing 13
InGeneron Raises USD20 Million in Series D Financing 13
Partnerships 14
Caladrius Biosciences Enters into Development Agreement with Sanford Research 14
Merger 15
Sanford Health Completes Merger With Medcenter One 15
North Country Health Services Completes Merger With Sanford Health 16
Equity Offering 17
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 17
Caladrius Biosciences to Raise USD21 Million in Private Placement of Shares 19
Acquisition 21
Sanford Health Plans To Acquire Fairview Health Services 21
Sanford Health Acquires Hematech, Drug Development Company 22
Sanford Health Completes Acquisition Of Hillsboro Medical Center 23
Sanford Health – Key Competitors 24
Sanford Health – Key Employees 25
Sanford Health – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 27
Recent Developments 28
Government and Public Interest 28
Sep 16, 2016: NIH selects Sanford for grant to move cancer research to clinical trials 28
Product News 29
Jul 19, 2016: Sanford physician assists in developing new treatment to prevent nausea, vomiting caused by chemotherapy 29
Apr 20, 2017: Oncology group chooses Sanford for first clinical trial 30
Mar 31, 2016: Type 1 diabetes cell therapy trial enrolls first patient at Sanford 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Sanford Health, Pharmaceuticals & Healthcare, Key Facts 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sanford Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sanford Health, Deals By Therapy Area, 2011 to YTD 2017 8
Sanford Health, Medical Devices Deals, 2011 to YTD 2017 9
Sanford Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sanford Health To Acquire Assets Of Clearwater Health 11
Sanford Health Acquires Lake Region Bone & Joint Surgeons 12
InGeneron Raises USD20 Million in Series D Financing 13
Caladrius Biosciences Enters into Development Agreement with Sanford Research 14
Sanford Health Completes Merger With Medcenter One 15
North Country Health Services Completes Merger With Sanford Health 16
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 17
Caladrius Biosciences to Raise USD21 Million in Private Placement of Shares 19
Sanford Health Plans To Acquire Fairview Health Services 21
Sanford Health Acquires Hematech, Drug Development Company 22
Sanford Health Completes Acquisition Of Hillsboro Medical Center 23
Sanford Health, Key Competitors 24
Sanford Health, Key Employees 25
Sanford Health, Other Locations 26
Sanford Health, Subsidiaries 26
Sanford Health, Joint Venture 27

★海外企業調査レポート[Sanford Health-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ProQR Therapeutics NV (PRQR):企業の財務・戦略的SWOT分析
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Robert Half International Inc (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Junex Inc (JNX):企業の財務・戦略的SWOT分析
    Junex Inc (JNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Eveon SAS:製品パイプライン分析
    Summary Eveon SAS (Eveon) engages in the designing, development and manufacturing the automated medical devices for the preparation and administration of complex drugs. The company also manufactures the customized products for the Pharma industry that develops from prototyping. It offers solutions t …
  • Inframark LLC:企業の戦略的SWOT分析
    Inframark LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Streamwide SA (ALSTW):企業の財務・戦略的SWOT分析
    Streamwide SA (ALSTW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nativis Inc-医療機器分野:企業M&A・提携分析
    Summary Nativis Inc (Nativis) is a clinical stage bio-electronics company. Its portfolio of pipeline candidates which are under development for various therapeutic areas include recurrent glioblastoma, brain metastisis, pain, rheumatoid arthritis, lung cancer and melanoma. The company’s lead product …
  • Jiuzhitang Co Ltd (000989):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiuzhitang Co Ltd (Jiuzhitang), formerly Labor Jiuzhitang Pharmacy, is a Chinese medicine manufacturing company. The company offers products such as shuxuetong injection, lujiao granule, liuwei dihuang wan pills, zuguang power, siqikang injection, luo hua zi zhu tablets, compound jiangzhi ta …
  • Torishima Pump Mfg Co Ltd (6363):企業の財務・戦略的SWOT分析
    Torishima Pump Mfg Co Ltd (6363) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hemispherx Biopharma Inc (HEB):製薬・医療:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • GeoVax Labs Inc (GOVX)-製薬・医療分野:企業M&A・提携分析
    Summary GeoVax Labs Inc (GeoVax) is a clinical-stage biotechnology company, which develops human vaccines for diseases caused by HIV, cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus o …
  • TriVascular Inc:製品パイプライン分析
    Summary TriVascular Inc (TriVascular), a subsidiary of Endologix Inc is a medical device company that researches, designs and manufactures technologies to provide optimal solutions for endovascular aortic repair. The company’s product comprise endovascular grafts and self-expanding stent grafts; ova …
  • UNIQA pojistovna, a.s.:企業の戦略・SWOT・財務情報
    UNIQA pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report Summary UNIQA pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Chronos Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Chronos Therapeutics Ltd (Chronos) is a developer of medications for degenerative and behavioural diseases of the brain and nervous system. The company offers research and development, screening, discovery, repositioning and acquisition programs. Its pipeline products comprise RDC5 neurodege …
  • Eastman Kodak Company:企業の戦略・SWOT・財務情報
    Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report Summary Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Parkland Fuel Corp (PKI):石油・ガス:M&Aディール及び事業提携情報
    Summary Parkland Fuel Corp (Parkland) is a downstream energy company. It markets various fuel and petroleum products, including gasoline, propane, lubricants, diesel, heating oil, and other petroleum products. The company maintains a portfolio of supply relationships, storage infrastructure, and thi …
  • ORBCOMM Inc (ORBC):企業の財務・戦略的SWOT分析
    ORBCOMM Inc (ORBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • WNDM Medical Inc (WNDM):医療機器:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • ULURU Inc (ULUR):医療機器:M&Aディール及び事業提携情報
    Summary ULURU Inc (ULURU) is a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wo …
  • Bonanza Creek Energy Inc (BCEI):企業の財務・戦略的SWOT分析
    Summary Bonanza Creek Energy Inc (Bonanza Creek) is an exploration and production company, engaged in acquisition, extraction and development of oil and related liquids which are rich in natural gas. The company uses horizontal drilling method for exploration and production of oil and natural gas an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆